PBCAR269A
PBCAR269A-01
Phase 1 gene_therapy terminated
Quick answer
PBCAR269A for Relapsed/Refractory Multiple Myeloma is a Phase 1 program (gene_therapy) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Relapsed/Refractory Multiple Myeloma
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- terminated